1004 Venture Partners
Venture capitalSan Diego · Pre-Seed–Seed · 2 people tracked
Investment thesis
1004 Venture Partners invests in early-stage companies building innovative technologies to advance healthy aging and longevity. The firm combines capital deployment with deep mentorship and community support, leveraging collective experience to guide founders through business development and growth milestones. The team emphasizes hands-on partnership with entrepreneurs, providing access to networks of industry professionals and key opinion leaders to accelerate impact in healthcare innovation.
Source: firm website, verified Aug 6, 2026.
Team · 2 people
from public directories
What they invest in
from 1 of 1 portfolio companiesBiotech ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathBiotechSan Diego, US
Gail Naughton(Executive Officer)Susan A. Knudson(Executive Officer)Richard W. Pascoe(Executive Officer, Director)Daniel Kisner, M.D.(Director)Steven Mento, Ph.D.(Director)Brian Satz, Esq.(Director)
Board seatDavid H. Crean· per SEC Form D · $5M raise · filed Jul 2022
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does 1004 Venture Partners invest at?
- 1004 Venture Partners invests at the Pre-Seed, Seed stages.
- What sectors does 1004 Venture Partners focus on?
- 1004 Venture Partners focuses on Healthtech, Longevity.
- Where is 1004 Venture Partners located?
- 1004 Venture Partners is headquartered in San Diego, US.
- Does 1004 Venture Partners lead rounds?
- Yes, 1004 Venture Partners leads investment rounds.
Media · Podcasts & interviews
featuring the teamBIO 2025 | SmartLabs | Investor Interview: Soyoung Park, 1004 Venture Partners
Bullpen Ventures · Soyoung Park
Images
Similar investors
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
AlleyCorp is a firm of technologists, investors, and entrepreneurs that both builds and invests in transformative companies.
Bold Capital Partners is a venture capital firm based in Los Angeles, California. Its portfolio includes companies such as Insilico Medicine, which applies artificial intelligence to biomarker development and drug discovery, reflecting a focus on frontier technologies in areas like AI-driven life sciences.
Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.